期刊文献+

脊柱关节炎患者D-二聚体和纤维蛋白原检测临床意义初探 被引量:4

Detection and clinical significance of blood of D-Dimer and fibrinogen in spondyloarthritis
下载PDF
导出
摘要 目的探讨检测D-二聚体和纤维蛋白原(Fib)在脊柱关节炎(SpA)患者中的临床意义。方法比较50例SpA、50例类风湿关节炎(RA)和50例SLE患者血中D-二聚体和Fib水平。并研究其与患者总体评分(PGS)、医生总体评分(DGS)、ESR、CRP、血小板、铁蛋白、HLA-B27等指标的关系。结果 SpA组、RA组、SLE组的血D-二聚体水平分别为(535±748)、(3 477±4 808)和(1 285±2 131)μg/L,SpA组血D-二聚体水平低于RA组和SLE组(P<0.05)。SpA组血Fib水平与RA组和SLE组比较差异无统计学意义。在SpA患者中,D-二聚体和Fib升高组的PGS和DGS均高于正常组患者(P<0.05)。D-二聚体升高组ESR、CRP和铁蛋白水平均高于D-二聚体水平正常组患者(P<0.05)。Fib升高组ESR、CRP和铁蛋白水平均高于Fib水平正常组患者(P<0.05)。D-二聚体和Fib与ESR、CRP、DGS具有相关性。D-二聚体水平与PGS具有相关性。结论SpA患者血中D-二聚体和Fib水平均有升高,且与疾病活动度密切相关。凝血-纤溶系统激活可能在SpA的病情发展和病理过程中发挥作用。 Objective To detect the clinical significance of D-Dimer and fibrinogen in the blood of spondyloarthritis (SpA) patients. Methods D-Dimer and fibrinogen of blood were detected among 50 patients with SpA, rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). further to investigate the re-lationship of other factors, such as patient global score (PGS) , doctor global score (DGS), erythrocyte sedi-mentation rate (ESR), C-reactvie protein (CRP), platelet (PLT), serum ferritin (SF), and Human Leuco- cyte Antigen-B27 ( HLA-B27 ). Results The titer of D-Dimer in SpA was significantly lower than that of the RA and SLE group [ (535 ± 748 ), (3477 ± 4808 ) and ( 1285 ± 2131 ) μg/L respectively, P 〈 0. 05 ]. The level of fibrinogen in three groups was no significant difference. PGS and DGS was higher in SpA patients with positive D-Dimer and fibrinogen than those with control group ( P 〈 0. 05 ). The values of ESR, CRP and SF in SpA patients with positive D-Dimer and fibrinogen were significantly higher than those in patients with control group. There was positive correlation between D-Dimer and fibrinogen and ESR ( r = 0. 37 and 0. 55 respec- tively, P 〈 0. 01 ), CRP ( r = 0. 54 and 0. 54 respectively, P 〈 0. 01 ), and DGS ( r = 0. 13 and 0. 19 respec-tively, P 〈 0. 01 ). D-Dimer had positive correlation with PGS (r = 0. 15, P 〈 0. 01 ). Conclusion The level of D-Dimer and fibrinogen in the blood of SpA patients in increased, and is positively correlated with disease activities. The results indicated that the activation of coagulation-fibrinolytic system may play a role in the path- ogenesis of SpA.
作者 王育凯
出处 《新医学》 2013年第7期472-475,共4页 Journal of New Medicine
关键词 脊柱关节炎 炎症性关节炎 D-二聚体 纤维蛋白原 Spondyloarthritis Inflammatory arthritis D-Dimer Fibrinogen
  • 相关文献

参考文献12

  • 1赵金霞,孙琳,张霞,刘湘源.血D-二聚体检测在类风湿关节炎中的临床意义[J].中华风湿病学杂志,2011,15(3):168-171. 被引量:19
  • 2薛红霞,崔华东,刘冬梅,付文轶,刘晓丹,杨丽丽,赵丽娟,张宁.D-二聚体及纤维蛋白原水平在类风湿关节炎中的临床意义[J].中国医科大学学报,2011,40(11):1004-1006. 被引量:30
  • 3李春,穆荣,任立敏,范文强,任长吉,栗占国.D-二聚体水平在系统性红斑狼疮的临床意义[J].中华内科杂志,2010,49(12):1039-1042. 被引量:25
  • 4Divecha H, Sattar N, Rumley A, et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: rele- vance of systemic inflammation. Clin Sci (Lond), 2005, 109: 171-176.
  • 5Peters MJ, van der Horst-Bminsma IE, Dijkmans BA, et al. Cardiovascular risk profile of patients with spondy-larthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum, 2004, 34: 585 -592.
  • 6Mathieu S, Motreff P, Soubrier M. Spondyloarthropa- thies: an independent cardiovascular risk factor? Joint Bone Spine, 2010, 77: 542-545.
  • 7Kimhi O, Caspi D, Bornstein NM, et al. Prevalence and risk factors of atherosclerosis in patients with psori- atic arthritis. Semin Arthritis Rheum, 2007, 36: 203- 209.
  • 8Lautermann D, Braun J. Ankylosing spondylitis-cardiac manifestations. Clin Exp Rheumatol, 2002, 20: S11- S15.
  • 9Prati C, Racadot E, Cedoz JP, et al. Thrombin genera- tion in ankylosing spondylitis. Clin Rheurrlatol, 2011,30: 511-514.
  • 10Busso N, Hamihon JA. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis. Arthritis Rheum, 2002, 46: 2268-2279.

二级参考文献35

  • 1杨文,初荣,王沈歌,曾倩.老年心脑血管疾病患者与老年及中青年健康者血浆D-二聚体和纤维蛋白原水平的比较(英文)[J].中国临床康复,2005,9(21):230-231. 被引量:12
  • 2Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis.Arthritis Rheum,1996,39:287-291.
  • 3Rajagopalan S,Somers EC,Brook RD,et al.Endothelial cell apoptosis in systemic lupus erythematosus:a common pathway for abnormal vascular function and thrombosis propensity.Blood,2004,103:3677-3683.
  • 4Fijnheer R,Blann AD.The endothelium and coagulopathy in systemic lupus erythematosus:hyperhomocysteinemia as a developing risk factor.J Rheumatol,2003,30:1400-1402.
  • 5Fancher TL,White RH,Kravitz RL.Combined use of rapid D dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis:systematic review.BMJ,2004,329:821.
  • 6Afeltra A,Vadacca M,Conti L,et al.Thrombosis in systemic lupus erythematosus:congenital and acquired risk factors.Arthritis Rheum,2005,53:452-459.
  • 7Bloom BJ,Tucker LB,Miller LC,et al.Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis.J Rheumatol,1998,25:1620-1625.
  • 8Nakashima M,Aoyagi T,Aratake K,et al.The levels of FDP,FDP-E and D-dimer in patients with rheumatoid arthritis.Ryumachi,1998,38:793-800.
  • 9van Hylckama Vlieg A,Montes R,Rosendaal FR,et al.Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis.J Thromb Haemost,2007,5:1449-1454.
  • 10Cotran RS.American Association of Pathologists president's address.New roles for the endothelium in inflammation and immunity.Am J Pathol,1987,129:407-413.

共引文献62

同被引文献55

  • 1刘斌,郭传友,刘文曲,吴宁,邢倩.血沉及C反应蛋白判定强直性脊柱炎病情活动的价值[J].中华内科杂志,2005,44(8):566-569. 被引量:31
  • 2雷莹辉,裴志刚,高国红.强直性脊柱炎并发的心脏病变[J].中国疗养医学,2007,16(6):365-365. 被引量:2
  • 3陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 4Bloom B J, Tucker L B, Miller L C, et al. Fibrin D-di- mer as a marker of disease activity in systemic onset ju- venile rheumatoid arthritis [ J ]. J Rheumatol, 1998,25 (8) :1620-1625.
  • 5van der Linden S, Valkenbnrg H A, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A propos- al for modification of the New York criteria [ J]. Arthritis Rheum, 1984,27(4) :361-368.
  • 6Garrett S, Jenkinson T, Kennedy L G, et al. A new ap- proach to defining disease status in ankylosing spondyli- tis: the Bath ankylosing spondylitis disease activity index [ J ]. J Rheumatol, 1994,21 ( 12 ) : 2286-2291.
  • 7Davidson S I, Wu X, Liu Y, et al. Association of ER- AP1 ,but not IL-23R, with ankylosing spondy].itis in a Han Chinese population [ J ]. Arthritis Rheum, 2009,60 ( 11 ) :3263-3268.
  • 8Davidson S l, Liu Y, Danoy P A, et al. Association of STAT3 and TNFRSF1 A with ankylosing spondylitis in Han Chinese[J]. Ann Rheum Dis, 2011,70(2):289- 292.
  • 9Lautermann D, Braun J. Ankylosing spondylitis-cardiac manifestations [ J 1- Clin Exp Bhrumatol, 2002,20 (6 Sup- ol 28) :Sll-S15.
  • 10Senocak O, Manisali M, Ozaksoy D, et al. Lung paren- chyma changes in ankylosing spondylitis; demonstration with high resolution CT and correlation with disease dura- tion[J]. Eur J Radiol, 2003,45(2) :117-122.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部